Frontlight ResearchEarly access
TerminatedNo phase
Quality of Life in Breast Cancer Survivors Who Were Pregnant During Their Cancer Treatment
Key facts
- Who runs it
- M.D. Anderson Cancer Center
- Where
- Houston, United StatesSee the site
- Trial code
- Status
- Terminated
- People taking part
- 30 people enrolled
- Started
- 1 Oct 2025
- Ended
- 9 Apr 2026
- Type of study
- Observational
- Treatments tested
- Questionnaire
- Record updated
- 17 April 2026
- Why it stopped
- \<75% participation
Who can take part
- Sex
- Women only
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 9 criteriaShow less
Who cannot take part
- Any woman who delayed and received their chemotherapy after delivery
- Any woman who was diagnosed with breast cancer before or after their pregnancy
- Any woman whom there is documentation of inability to provide consent in the medical record
Other criteria
- Eligibility Criteria
- Female, any current age and any age at diagnosis
- Documented diagnosis of breast cancer during pregnancy
- Documentation of receiving chemotherapy during pregnancy
- Alive with no evidence of disease at time of recruitment
- Able to reach and speak English
Where in United States
- MD Anderson Cancer CenterHouston, United States
About the trial
What the trial wants to find out
To assess the quality of life for women who were pregnant during their breast cancer treatment.
Treatments tested
- Questionnaire
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Record updated
- 17 April 2026